NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Glyphic Biotechnologies

Glyphic Biotechnologies

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.glyphic.bio/

Last Round

Series A

Feb 16, 2024

Total Funding Raised

$44.79M

Company Overview

Glyphic Biotechnologies is a biotechnology company that develops a single-molecule, massively parallel, de novo next-generation protein sequencing platform to enable novel therapeutics and diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Infrastructure

Keywords

proteomicssingle-molecule sequencingprotein sequencingnext-gen proteomicsbiomarker discoverydrug discoveryprecision medicinebasecallingbioinformaticsnanopore sequencingproteomics instrumentationAI-native biotechclinical diagnosticslife sciences tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Glyphic Biotechnologies Comparables

Compare Glyphic Biotechnologies with similar companies based on industry and business-model similarity.

Glyphic Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Glyphic Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 16, 2024
GrantSep 15, 2023
GrantSep 6, 2022
SeedJul 8, 2021

Key People

Founding team and executive leadership

Eugene Tu

Chief Technology Officer

Executive Team

Kyle Lapham

Chief Operating Officer

Executive Team

Glyphic Biotechnologies Investors

Notable investors and investment history

Glyphic Biotechnologies investors
InvestorRounds
Zeon VenturesSeries A
NIH RADxGrant
Cantos VenturesSeed
FoundersX VenturesSeries A, Seed
ARTIS VenturesSeries A, Seed
Osage University PartnersSeries A, Seed
LongeVCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 16, 2024

    $33M round completed.

Glyphic Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Glyphic Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Glyphic Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range34
Year Founded2021
Last FundingFeb 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.